Do I need a prescription for tirzepatide/glycine injection?

Yes. Tirzepatide is a prescription-only medication in the United States. A licensed provider must review your health history and determine whether it is appropriate for you before it can be dispensed.

How does ordering and shipping work?

After you complete a health questionnaire or consultation, a licensed provider reviews your information. If a prescription is issued, the medication is prepared and shipped from a licensed U.S. pharmacy in temperature-appropriate packaging.

How is Tirzepatide/Glycine 17/5 mg/mL different from Mounjaro?

Mounjaro is the FDA-approved brand-name tirzepatide product. This compounded version contains tirzepatide with glycine and is prepared by a licensed pharmacy pursuant to a prescription; compounded drugs are not FDA-approved, so discuss the difference with your provider or pharmacist.

How do I take tirzepatide injection?

It is injected under the skin (subcutaneously) once weekly, on the same day each week, in the abdomen, thigh, or upper arm. Most patients start at 2.5 mg weekly, with gradual dose increases directed by their provider.

What are the most common side effects of tirzepatide?

The most common side effects are gastrointestinal, including nausea, diarrhea, decreased appetite, vomiting, and constipation. These are often most noticeable when starting treatment or increasing the dose and tend to lessen over time; contact your provider if they persist or worsen.

Tirzepatide/Glycine 17/5 mg/mL

Name: Tirzepatide/Glycine 17/5 mg/mL
Brand: All Family Pharmacy
SKU: tirzepatide-glycine-17-5-mg-ml
Availability: InStock

Generic For: Mounjaro

4.8 Google Star Rated · 200,000+ Orders Shipped

Tirzepatide/Glycine 17/5 mg/mL — All Family Pharmacy

Tirzepatide/Glycine 17/5 mg/mL is a compounded injectable formulation of tirzepatide, the active ingredient in Mounjaro, a dual GIP and GLP-1 receptor agonist. It is prescribed to improve blood sugar control in adults with type 2 diabetes and may be prescribed to support weight management alongside diet and exercise. After a licensed provider reviews your health information and issues a prescription, your medication ships from a licensed U.S. pharmacy.

Compare all Tirzepatide options →

Select Quantity *

4 ML 8 ML

90-day supply · $137.50/mL

How It Works

Select your medication
Licensed providers review & prescribe
Our licensed U.S. pharmacists fill your prescription
Delivered to you as soon as the next day

Price: $550.00

HSA/FSA Eligible

Get Started

*Doctor visit fee & delivery cost not included in price. Refills at provider discretion.

Pharmacist Support Fast Shipping Licensed U.S. Pharmacy

Buy Tirzepatide/Glycine 17/5 mg/mL Injection Online

A GLP-1/GIP receptor agonist injection for type 2 diabetes and chronic weight management

Medically reviewed by David Paul Mackarey, RPh, Pharmacist-in-Charge

Tirzepatide/Glycine 17/5 mg/mL Quick Facts

Drug class	GIP/GLP-1 receptor agonist
Treats	Type 2 diabetes, chronic weight management
Form	Injection
Typical dosing	INJECT ONCE A WEEK. FOLLOW DIRECTIONS ON ENCLOSED SHEET. Dispense alcohol prep pads and 1 mL syringes QS.
Prescription required	Yes — prescription only

What Is Tirzepatide/Glycine 17/5 mg/mL?

Tirzepatide/Glycine 17/5 mg/mL is a compounded injection containing tirzepatide, the same active ingredient found in the brand-name medication Mounjaro. Tirzepatide works by activating two hormone receptors — GIP and GLP-1 — that help regulate blood sugar, slow stomach emptying, and reduce appetite. It is used together with diet and exercise to improve glycemic control in adults with type 2 diabetes, and tirzepatide is also FDA-approved under another brand name for chronic weight management. It is administered as a subcutaneous injection once weekly and requires a prescription from a licensed provider.

What Does Tirzepatide/Glycine 17/5 mg/mL Treat?

Type 2 diabetes mellitus (to improve blood sugar control in adults)
Chronic weight management in adults with obesity
Chronic weight management in adults who are overweight with a weight-related condition
Used as an adjunct to a reduced-calorie diet and increased physical activity

Tirzepatide/Glycine 17/5 mg/mL Dosage

Start: 2.5 mg subcutaneously once weekly for 4 weeks.
Then increase to 5 mg subcutaneously once weekly; may increase in 2.5 mg increments after at least 4 weeks at current dose.
Maximum: 15 mg subcutaneously once weekly.

Your prescriber will determine the dose and duration that are right for you. Always follow the directions on your prescription label.

Tirzepatide/Glycine 17/5 mg/mL Side Effects

Common side effects

Nausea
Diarrhea
Decreased appetite
Vomiting
Constipation
Indigestion (dyspepsia)
Abdominal pain
Injection site reactions

Serious side effects

Stop taking this medication and seek medical attention right away if you experience:

Severe allergic reactions (rash, swelling, difficulty breathing)
Pancreatitis (severe abdominal pain that may radiate to the back)
Gallbladder problems (gallstones, upper abdominal pain, fever, jaundice)
Severe low blood sugar, especially with insulin or sulfonylureas
Kidney injury, often related to dehydration from vomiting or diarrhea
Vision changes in patients with diabetic retinopathy

Warnings & Interactions

Boxed warning: risk of thyroid C-cell tumors; do not use with a personal or family history of medullary thyroid carcinoma or MEN 2
Do not use if you have had a serious allergic reaction to tirzepatide
Not recommended in patients with a history of pancreatitis
May reduce the effectiveness of oral birth control; use backup contraception when starting or increasing dose
Increased hypoglycemia risk when combined with insulin or sulfonylureas; dose adjustments may be needed
Slows gastric emptying and may affect absorption of oral medications
Not recommended during pregnancy; discuss with your provider if pregnant or planning pregnancy

Tell your prescriber about all medications, supplements, and health conditions before starting tirzepatide/glycine 17/5 mg/ml.